Yiannis Kallis

P44 Combination of obeticholic acid with bezafibrate, with or without ursodeoxycholic acid, in high-risk patients with primary biliary cholangitis: a single centre experience

Arron Jones, Yiannis Kallis

gb (code pays fourni par la source)

P46 Ethnic variation in disease progression and treatment in primary biliary cholangitis: results from a tertiary hepatology centre

Pallab Mandal, S. S. El‐Saadany, Yiannis Kallis

gb (code pays fourni par la source)

Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial

Cynthia Levy, George Abouda, Bahri M. Bilir, Alan Bonder et autres

us, gb, es, it, ca, pt, de, fr (code pays fourni par la source)

OS-089 Elafibranor for primary sclerosing cholangitis: the ELMWOOD phase II randomised controlled trial

Cynthia Levy, George Abouda, Bahri M. Bilir, Alan Bonder et autres

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

Gideon M. Hirschfield, Christopher L. Bowlus, Marlyn J. Mayo, Andreas E. Kremer et autres

ca (code pays fourni par la source)

Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial

Louise China, Thaís Tittanegro, Dominic Crocombe, Ewan Forrest et autres

gb (code pays fourni par la source)

Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: data from the ATTIRE trial

Thaís Tittanegro, Louise China, Ewan Forrest, Yiannis Kallis et autres

gb (code pays fourni par la source)

ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis—study protocol for an interventional randomised controlled trial

Dominic Crocombe, Norin Ahmed, Indran Balakrishnan, Ekaterina Bordea et autres

gb (code pays fourni par la source)

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

Carla Fiorella Murillo Perez, Holly Fisher, Shaun Hiu, Dorcas Kareithi et autres

ca, gb, us, nl, it, be, de, es, gr, at, fr (code pays fourni par la source)

Evaluating the Role of Antibiotics in Patients Admitted to Hospital With Decompensated Cirrhosis: Lessons From the ATTIRE Trial

Rishen Kutmutia, Thaís Tittanegro, Louise China, Ewan Forrest et autres

gb (code pays fourni par la source)

UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis

Nadir Abbas, Emma Culver, Douglas Thorburn, Neil Halliday et autres

gb, ca (code pays fourni par la source)

Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

Heather J. Cordell, James J. Fryett, Kazuko Ueno, Rebecca Darlay et autres

gb, jp, cn, us, it, ca (code pays fourni par la source)